Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Comment by Jericomileon Aug 23, 2020 9:53am
230 Views
Post# 31443038

RE:Short Report...They're Back

RE:Short Report...They're BackThis is probably one of the most accurate posts in a while. Also, charts late Thursday afternoon indicated that RVV is going nowhere, anytime soon. The shorts are going to try and bring this down to .20 unless, there is another NR. The stock will rise another 5 to 7 cents and go down again. Its a shame, because RVV has a lot of potential but the shorts are going to continue to drop this. As I stated before, I am sure over 90% over investors in this stock took profit and are sitting on free trading shares. If you have patience and free trading shares, hold on. As for those who messaged me and I recommended to buy WAVE at .155 on Thursday, hold onto to your shares. The float is EXTREMELY low. Wave will fly on any NR. Talk with their IR and you will get a better idea. They have a lot in the pipeline, forthcoming. Regarding shorts for Wave, there are 1.2M shorts that will have to cover, with only 13M tradeable shares. This is absolutely amazing, to say the least. Also, what is very impressive about Wave is that, there is 50% discount to what it cost the insiders, who are holding an IMPRESSIVE 75% of the float at .50 That says it all. Best of luck to RVV shareholders and those who bought into Wave, which I know most of you did, including PINK!
<< Previous
Bullboard Posts
Next >>